Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with FCT, Universidade NOVA de Lisboa

14 Sep 2016 11:50

RNS Number : 8333J
Frontier IP Group plc
14 September 2016
 

AIM: FIPP

14 September 2016

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Agreement with the Faculty of Science and Technology of Universidade NOVA de Lisboa

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has today signed an agreement with the Faculty of Science and Technology within the Universidade NOVA de Lisboa, Portugal ("FCT NOVA") to assist with its spin-off and licensing activities emerging from its research programmes. This partnership is Frontier IP's second in Portugal and reflects the Group's view that there is significant opportunity in the region.

 

The Universidade NOVA de Lisboa is a research-intensive university (QS Top Universities 2016) and FCT NOVA, its engineering school, has particular research strengths in Materials, Environment, Energy, Biotechnology, Conservation and Restoration. Frontier IP and FCT NOVA will work together to maximise the commercial value of intellectual property developed within or owned by FCT NOVA. Frontier IP will receive a share of equity in each spin-off company created by FCT NOVA, as well as a share in the licensing revenue it receives.

 

FCT NOVA is an active research collaborator, both within Portugal and internationally, and its partners include Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin, amongst others. The collaboration with Frontier IP aims to accelerate value creation from the research generated within FCT NOVA and provide access to early stage funding, commercialisation expertise and a wider network of industrial partners.

 

The signing of the agreement was attended by Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes. Addressing the audience, the Ambassador emphasised the importance of effective commercialisation of the intellectual property being generated through the investment in research and development in Portugal's universities. The UK has strong experience of intellectual property commercialisation and it has been a principle focus for British universities to develop a portfolio of intellectual property which has relevance to the business world.

 

Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes, said:

 

"I am delighted by the announcement of this important agreement between Frontier IP and FCT NOVA, which will drive the commercialisation of intellectual property from one of the leading Portuguese universities, which has a strong reputation for investment in research and development. This agreement represents a further strengthening of collaboration between Portugal and the United Kingdom."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"We are delighted that FCT NOVA has chosen us as its commercialisation partner. This agreement gives us access to FCT NOVA's excellent research base and builds on the strong relationships with the industrial partners and academic institutions which we have already established in the region. We are looking forward to working with FCT NOVA to further develop and commercialise its strong intellectual property portfolio."

 

Dr. Fernando Santana, Director of FCT NOVA, said:

 

"Frontier IP has a strong reputation in the commercialisation of university-based technologies. We hope that this agreement will bring increased international visibility to FCT NOVA's portfolio, making it an even more successful institution by maximizing the impact of its knowledge. This shows FCT NOVA's commitment to innovation, which benefits the institution and the wider society it serves."

 

Enquiries

 

Frontier IP Group Plc

 

T: 0131 240 1251

Neil Crabb, Chief Executive

 

 

Company website: www.frontierip.co.uk

 

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

 

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

 

 

David Banks, Sales

 

 

 

 

 

Peterhouse Corporate Finance Limited

(Joint Broker)

 

T: 020 7469 0935

Lucy Williams

 

 

 

 

 

Kreab

 

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

 

About Universidade NOVA de Lisboa, Faculty of Science and Technology

http://www.fct.unl.pt

FCT NOVA is one of the most prestigious Portuguese engineering and science public schools and it is engaged in extensive research activity developed in 16 research centres involving 1600 PhD and Master's students and a total of 550 academic staff (90% holding a Ph.D). FCT NOVA partners with foreign universities such as the Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin to offer some of its advanced study programs. The entrepreneurial drive of the students and graduates of FCT NOVA has led to many successful spin-offs that transfer knowledge to the market and help create value and social impact.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLLFSIARISLIR
Date   Source Headline
15th Nov 201812:37 pmRNSGrant of Options
15th Nov 201810:05 amRNSExscientia acquires Kinetic Discovery
15th Nov 20189:30 amRNSPlacing to raise £2.49 million
15th Nov 20189:25 amRNSFinal Results
30th Oct 20187:00 amRNSSecond Portuguese spin out: Des Solutio
19th Oct 20187:00 amRNSMolendotech signs collaboration agreement with G's
5th Oct 20187:00 amRNSDIT hails Frontier IP's Portuguese success
27th Sep 20187:00 amRNSChange of Adviser
26th Sep 20185:12 pmRNSDirector Declaration
24th Sep 20182:30 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSAmprologix to develop new antibiotics with Ingenza
18th Sep 20181:56 pmRNSAlusid raises £1.34m to scale up manufacturing
17th Sep 20187:00 amRNSAB Sugar Head of Innovation joins Frontier IP
30th Aug 201812:39 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSTVG awarded £50,000 anti-bacterial vaccine grant
7th Aug 20187:00 amRNSPortfolio news - first Portuguese spin out
6th Aug 20187:00 amRNSFieldwork Robotics agreement with Hall Hunter
2nd Aug 20187:00 amRNSFrontier IP partners with UK DIT in Portugal
16th Jul 20187:00 amRNSTarsis Collaboration with Crop-Protection Company
11th Jul 20187:00 amRNSInnovate UK grant for Pulsiv Solar
19th Jun 20187:00 amRNSCambridge Material Testing Solutions
15th May 20187:00 amRNSPalintest launches Molendotech bathing water test
18th Apr 20184:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSIncreased Equity Holding in Fieldwork Robotics
27th Mar 20187:00 amRNSHALF-YEAR RESULTS, 6 MONTHS TO 31 DECEMBER 2017
26th Mar 20187:00 amRNSTeam Expansion and London Office
19th Feb 20187:00 amRNSPortfolio News - Molendotech Secures First Funding
29th Jan 20187:00 amRNSCapital Markets Day
29th Jan 20187:00 amRNSPortfolio News - Molendotech Collaboration
18th Dec 20177:00 amRNSCapital Markets Day
7th Dec 201711:50 amRNSResult of AGM
8th Nov 20177:00 amRNSPosting of Annual Report and Notice of AGM
30th Oct 20175:15 pmRNSHolding(s) in Company
30th Oct 201712:00 pmRNSPortfolio News PulsiV Granted Two US Patents
24th Oct 20177:00 amRNSFinal Results
9th Oct 20177:00 amRNSExscientia Wins Emerging Biotech Company Award
28th Sep 20177:00 amRNSExscientia announces investment from Evotec
25th Sep 20171:12 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSAlusid extends range at London Design Festival
7th Sep 20177:00 amRNSCSI launches novel sensor system at IFA Berlin
8th Aug 20177:00 amRNSNew Portfolio Company - The Vaccine Group
28th Jul 20173:26 pmRNSHolding(s) in Company
20th Jul 20177:00 amRNSPortfolio News- Nandi Proteins Limited Fundraising
11th Jul 20174:38 pmRNSHolding(s) in Company
5th Jul 20177:00 amRNSNew Portfolio Company - MolEndoTech
3rd Jul 20177:00 amRNSExscientia announces major GSK collaboration
11th May 20177:00 amRNSGrant of Options
9th May 201712:05 pmRNSRoyal Society of Chemistry Nominations
9th May 201711:25 amRNSExscientia announces major Sanofi collaboration
30th Mar 20177:00 amRNSHalf-Year Results for the 6 Months to 31 Dec 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.